MD | Cardiologist at IRCCS Neuromed (Syncope Unit) |Passionate about electrophysiology and cardiac pacing.
Joined January 2021
- Tweets139
- Following411
- Followers264
- Likes1.1K
Marco Micillo retweeted
🧵Novel approaches to ventricular pacing @hrs_journal October 2026 now available online #EPeeps
⭐️3 innovative approaches to challenging ventricular pacing scenarios:
→ Pacing strategy after transcatheter tricuspid valve intervention (TTVI)
→ “Pure CS” biventricular pacing using 2 CS leads
→ Thebesian vein lead placement as an alternative route for LV pacing
✴️First, Tat et al. examined pacing strategies in 137 pts undergoing TTVR (n=69) or TEER (n=68).
➡️Among 103 pts without pre-existing PPM, 15% developed a new pacing indication—20% after TTVR and 9% after TEER.
➡️CS pacing was successful in 9/13 attempts and leadless pacing in 3/5.
➡️CS anatomy was the major limitation for CS pacing, while leadless PPM was challenging d.t. interaction with the TTVI apparatus.
🎯Take-home: Anticipate pacing before TTVI. The optimal approach depends on TTVR vs. TEER, CS anatomy, underlying rhythm and LVEFn—and should be part of multidisciplinary preprocedural planning.
heartrhythmjournal.com/artic…
Marco Micillo retweeted
🎉 Excited to announce the publication of the first international clinical consensus statement on the management of patients with AT
It’s been the greatest pleasure and honor being the document coordinator and part of the writing group 🫀🙏🏼 @C_Meyer_MD
📎academic.oup.com/europace/ad…
Marco Micillo retweeted
Another fantastic review from our imaging group has just been published 🫀💪
Cardiac CT in Non-Obstructive Coronary Artery Disease (NOCAD): A Literature Review
@ritapavasini87 @ElisabettaBex @GianlucaCampo78
It was a pleasure to participate in the 86th Congress of the Italian Society of Cardiology. Every year, it is a gathering of colleagues and friends, where we can discuss projects and ideas.
I would like to thank @italian_cot for invite me to talk about ventricular tachycardia.
Marco Micillo retweeted
Research | Yamazoe et al. show that B-cell derived autoantibodies contribute to the development of atrial fibrillation, suggesting that targeting the humoral immune response may represent a viable therapeutic approach.
doi.org/10.1038/s44161-025-0…
rdcu.be/eNFJV
A brief overview of Nerinetide and the potential benefits of PSD-95 inhibition, which reduces neuronal excitotoxicity caused by the NMDA receptor pathway.
Marco Micillo retweeted
📈 Highly Accessed Paper 📈
💡"Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles" by Marco Valerio Mariani et al.
👉Read the full article here: mdpi.com/2308-3425/11/8/243
#openaccess #MDPI #cardiology
Lights and shadows about the OPTION trial
A short comment on #ESCStrokeBlog about LAA closure in pts undergoing AF ablation
🖇️Blog: tinyurl.com/mr38wn4y
🖇️Original paper: tinyurl.com/hx2a75jz
@escardio @NEJM #LAAO #Afib
🚨Lights and shadows about the OPTION trial
Check out our latest #ESCStrokeBlog by @MarcoMicillo1! 👀
🖇️Blog: tinyurl.com/mr38wn4y
🖇️Original paper: tinyurl.com/hx2a75jz
@escardio @NEJM #LAAO #Afib
@JacopoImberti @L_Bergamaschi @Fra_Vitali90 @annapodlasek @LiverpoolCCS
Marco Micillo retweeted
🚨Lights and shadows about the OPTION trial
Check out our latest #ESCStrokeBlog by @MarcoMicillo1! 👀
🖇️Blog: tinyurl.com/mr38wn4y
🖇️Original paper: tinyurl.com/hx2a75jz
@escardio @NEJM #LAAO #Afib
@JacopoImberti @L_Bergamaschi @Fra_Vitali90 @annapodlasek @LiverpoolCCS
Marco Micillo retweeted
What are LBBP and LVSP really doing to the LV?
Check out our latest drop!
sciencedirect.com/science/ar…
@MatteoBertini5 @malagu_m @Fra_Vitali90 @GAzzl95 @stefanoclo1 @MelpAngelo @MartinaRaffele @MarcoMicillo1 @cristinaballa1 @ritapavasini87 @NicolaBianchi95 @marcodeppo
Marco Micillo retweeted
🙌Game-changing real-world data from SWEDEHEART!
📰Leosdottir et al., JACC 2024 jacc.org/doi/10.1016/j.jacc.…
Title: Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes
👩🦰🧑🦰Population: >71,000 post-MI patients on high-intensity statins
Groups:
1️⃣ Ezetimibe within 6 months of MI
2️⃣ Ezetimibe 6–12 months post-MI
3️⃣ No ezetimibe
🤩Findings: Early ezetimibe → ↓ 22% in MACE (HR 0.78 [0.70–0.86]) vs. late initiation
☝️Compared to no ezetimibe → HR 0.85 [0.79–0.91] ☝️NNT = 53 to prevent 1 MACE with early initiation
☝️Mortality also significantly reduced with early use
👉Delaying ezetimibe after MI = missed opportunity to prevent events.
The message is clear: Start combination lipid-lowering therapy early—not when LDLc remains high, but when risk is high.
@society_eas
@ProfKausikRay
Marco Micillo retweeted
2nd Consensus Document of the day at #EHRA2025
📚Consensus Paper on Antiarrhythmic Drugs
Manuscript now available in @EuropaceEiC
🔗🆓 academic.oup.com/europace/ad…
@BorianiGiuseppe @joselmerino
Marco Micillo retweeted
🎄 Buone Feste dal Team ICoT🌟
Con l’arrivo delle feste, vogliamo augurare a ognuno di voi un Natale sereno e un 2025 pieno di gioia, soddisfazioni e nuovi traguardi! 🎅🏼
Tantissimi auguri 🎁 🎄✨
Il Team ICoT🫀
Marco Micillo retweeted
#Epeeps, check out our latest work!
@malagu_m @MatteoBertini5
Ultrasound-guided versus Fluoro-guided Axillary Venous Access for Cardiac Implantable Electronic Devices: A Patient-Based Meta-analysis academic.oup.com/europace/ar…
Marco Micillo retweeted
🫀“ TAVI and CAD: Timing qnd Strategies of Optimal Treatment “ 💊
🖇️La pillola 💊di oggi è a cura della 🫀Prof.ssa Anna Franzone , 📍dell ‘Università degli studi di Napoli Federico II.
Seguici sul Canale You Tube buff.ly/3XHWf6F
e su Spotify!buff.ly/3MBxMcw
Marco Micillo retweeted
‼️Trial From #ESCcongress🫀
📌Aspirin versus Clopidogrel Monotherapy After PCI: 1-Year Follow-up of the STOPDAPT-3 Trial
📂
Eur Heart J #ESCCongress
#esccongress2024
🖇️
Read more : academic.oup.com/eurheartj/a…
Marco Micillo retweeted
🔥🔥🔥
Check out the simultaneous publication on the NSTEMI vs STEMI subanalysis of @theFIRE_trial @JACCJournals
🗣️Consistent benefit of physiology-guided complete revasc in NSTEMI and STEMI patients! – at East Ham, London
Physiology-guided complete #revascularization may trump culprit-only approaches in older patients suggests #ESCCongress late-breaker: bit.ly/4g7ADaX
#JACC #STEMI #NSTEMI #cvMI
Marco Micillo retweeted
#AI transforms #Cardiology. Our State-of-the-Art Review is now online in @ehj_ed
Deeply honored to be part of this exceptional team @TomLuscher @Charis_Oxford @drpaulfriedman @Fabri84Dascenzo
🌐 doi.org/10.1093/eurheartj/eh…
🌐grace-3.com
@ESC_Journals @SwissCardio
